Literature DB >> 24581549

Genetic modifiers and subtypes in schizophrenia: investigations of age at onset, severity, sex and family history.

Sarah E Bergen1, Colm T O'Dushlaine2, Phil H Lee3, Ayman H Fanous4, Douglas M Ruderfer5, Stephan Ripke6, Patrick F Sullivan7, Jordan W Smoller8, Shaun M Purcell5, Aiden Corvin9.   

Abstract

Schizophrenia is a genetically and clinically heterogeneous disorder. Genetic risk factors for the disorder may differ between the sexes or between multiply affected families compared to cases with no family history. Additionally, limited data support a genetic basis for variation in onset and severity, but specific loci have not been identified. We performed genome-wide association studies (GWAS) examining genetic influences on age at onset (AAO) and illness severity as well as specific risk by sex or family history status using up to 2762 cases and 3187 controls from the International Schizophrenia Consortium (ISC). Subjects with a family history of schizophrenia demonstrated a slightly lower average AAO that was not significant following multiple testing correction (p=.048), but no differences in illness severity were observed by family history status (p=.51). Consistent with prior reports, we observed earlier AAO (p=.005) and a more severe course of illness for men (p=.002). Family history positive analyses showed the greatest association with KIF5C (p=1.96×10(-8)), however, genetic risk burden overall does not differ by family history. Separate association analyses for males and females revealed no significant sex-specific associations. The top GWAS hit for AAO was near the olfactory receptor gene OR2K2 (p=1.52×10(-7)). Analyses of illness severity (episodic vs. continuous) implicated variation in ST18 (p=8.24×10(-7)). These results confirm recognized demographic relationships but do not support a simplified genetic architecture for schizophrenia subtypes based on these variables.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Association; GWAS; Gender; psychosis

Mesh:

Year:  2014        PMID: 24581549      PMCID: PMC4422643          DOI: 10.1016/j.schres.2014.01.030

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  42 in total

1.  Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease.

Authors:  Katrin Beyer; José I Lao; Pilar Latorre; Aurelio Ariza
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

Review 2.  Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework.

Authors:  A H Fanous; K S Kendler
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

3.  Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.

Authors:  Melanie Wissmann; Na Yin; Judith M Müller; Holger Greschik; Barna D Fodor; Thomas Jenuwein; Christine Vogler; Robert Schneider; Thomas Günther; Reinhard Buettner; Eric Metzger; Roland Schüle
Journal:  Nat Cell Biol       Date:  2007-02-04       Impact factor: 28.824

4.  Age at drinking onset and alcohol dependence: age at onset, duration, and severity.

Authors:  Ralph W Hingson; Timothy Heeren; Michael R Winter
Journal:  Arch Pediatr Adolesc Med       Date:  2006-07

5.  Sporadic vs familial classification given etiologic heterogeneity: I. Sensitivity, specificity, and positive and negative predictive value.

Authors:  K S Kendler
Journal:  Genet Epidemiol       Date:  1987       Impact factor: 2.135

6.  A population based elaboration of the role of age of onset on the course of schizophrenia.

Authors:  Jonathan Rabinowitz; Stephen Z Levine; Heinz Häfner
Journal:  Schizophr Res       Date:  2006-09-07       Impact factor: 4.939

Review 7.  Gender differences in age at onset of schizophrenia. An overview.

Authors:  M C Angermeyer; L Kühn
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988-09

8.  Earlier puberty as a predictor of later onset of schizophrenia in women.

Authors:  R Z Cohen; M V Seeman; A Gotowiec; L Kopala
Journal:  Am J Psychiatry       Date:  1999-07       Impact factor: 18.112

9.  Gender and age at onset in schizophrenia: impact of family history.

Authors:  P Gorwood; M Leboyer; M Jay; C Payan; J Feingold
Journal:  Am J Psychiatry       Date:  1995-02       Impact factor: 18.112

10.  Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia.

Authors:  E S Lips; L N Cornelisse; R F Toonen; J L Min; C M Hultman; P A Holmans; M C O'Donovan; S M Purcell; A B Smit; M Verhage; P F Sullivan; P M Visscher; D Posthuma
Journal:  Mol Psychiatry       Date:  2011-09-20       Impact factor: 15.992

View more
  22 in total

Review 1.  Neuroimmunology and neuroepigenetics in the establishment of sex differences in the brain.

Authors:  Margaret M McCarthy; Bridget M Nugent; Kathryn M Lenz
Journal:  Nat Rev Neurosci       Date:  2017-06-22       Impact factor: 34.870

Review 2.  Genetics of Childhood-onset Schizophrenia 2019 Update.

Authors:  Jennifer K Forsyth; Robert F Asarnow
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2019-10-17

Review 3.  Prefrontal dysfunction and a monkey model of schizophrenia.

Authors:  Ping Mao; Ding Cui; Xu-Dong Zhao; Yuan-Ye Ma
Journal:  Neurosci Bull       Date:  2015-03-31       Impact factor: 5.203

4.  Whole-Genome Sequencing and Integrative Genomic Analysis Approach on Two 22q11.2 Deletion Syndrome Family Trios for Genotype to Phenotype Correlations.

Authors:  Jonathan H Chung; Jinlu Cai; Barrie G Suskin; Zhengdong Zhang; Karlene Coleman; Bernice E Morrow
Journal:  Hum Mutat       Date:  2015-07-02       Impact factor: 4.878

5.  NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches.

Authors:  Carmen Almodóvar-Payá; Maria Guardiola-Ripoll; Maria Giralt-López; Carme Gallego; Pilar Salgado-Pineda; Salvador Miret; Raymond Salvador; María J Muñoz; Luisa Lázaro; Amalia Guerrero-Pedraza; Mara Parellada; María I Carrión; Manuel J Cuesta; Teresa Maristany; Salvador Sarró; Lourdes Fañanás; Luis F Callado; Bárbara Arias; Edith Pomarol-Clotet; Mar Fatjó-Vilas
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

6.  Frequent Comorbidity and Predictors of Social Anxiety in Persons With Schizophrenia: A Retrospective Cohort Study.

Authors:  Alyson Gorun; Kristina Cieslak; Jill Harkavy-Friedman; Andrew Deptula; Deborah Goetz; Raymond Goetz; Dolores Malaspina
Journal:  Prim Care Companion CNS Disord       Date:  2015-09-03

7.  Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia-a multicenter harmonized diffusion tensor imaging study.

Authors:  Johanna Seitz-Holland; Suheyla Cetin-Karayumak; Matcheri Keshavan; Marek Kubicki; Joanne D Wojcik; Amanda Lyall; James Levitt; Martha E Shenton; Ofer Pasternak; Carl-Fredrik Westin; Madhura Baxi; Sinead Kelly; Raquelle Mesholam-Gately; Mark Vangel; Godfrey Pearlson; Carol A Tamminga; John A Sweeney; Brett A Clementz; David Schretlen; Petra Verena Viher; Katharina Stegmayer; Sebastian Walther; Jungsun Lee; Tim Crow; Anthony James; Aristotle Voineskos; Robert W Buchanan; Philip R Szeszko; Anil K Malhotra; Yogesh Rathi
Journal:  Mol Psychiatry       Date:  2021-01-22       Impact factor: 13.437

8.  Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data.

Authors:  Hiroyo Kuwabara; Yoshimichi Saito; Jörg Mahlich
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-01       Impact factor: 2.570

Review 9.  Focus on psychosis.

Authors:  Wolfgang Gaebel; Jürgen Zielasek
Journal:  Dialogues Clin Neurosci       Date:  2015-03       Impact factor: 5.986

10.  Why does age of onset predict clinical severity in schizophrenia? A multiplex extended pedigree study.

Authors:  Christie W Musket; Susan S Kuo; Petra E Rupert; Laura Almasy; Ruben C Gur; Konasale Prasad; Joel Wood; David R Roalf; Raquel E Gur; Vishwajit L Nimgaonkar; Michael F Pogue-Geile
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2020-08-19       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.